SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...

Hepatocellular carcinoma (HCC) is a common cancer, and the body’s immune responses greatly affect its progression and the prognosis of patients. Immunological suppression and the maintenance of ...

This Research Topic is part of the series of "Hepatocellular Carcinoma: Novel Treatment Strategies":Hepatocellular Carcinoma: Novel Treatment Strategies - ...

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver ...

Misconceptions about HCC often lead to stigma, but early detection can significantly improve treatment outcomes and survival ...

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...

The treatment plan for liver cancer can vary depending on the stage, size, and location of the tumor. Common options include surgery, ablation, cryotherapy, immunotherapy, and targeted drug therapy.

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...

Liver cancer remains one of the deadliest cancers worldwide, something that escapes early detection. Understand liver cancer, ...

MDSCs, myeloid-derived suppressor cells; ILCs, Innate lymphoid cells; NK2, Natural killer; Th2, T helper 2; Treg, regulatory T cells; NKT, natural killer T. Hepatocellular carcinoma (HCC) is a primary ...